ROTHERA MARK (President and CEO) purchased 100K shares of VIRACTA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $49.4K. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/4/2023ACC: 0001209191-23-057239
DirectorOfficer· President and CEO
Since Sep 2022
+100K
Net shares
Net buyer
$49.4K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
100K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+52.09K
Price / share
$0.49
Trade value
$25.73K
% of position
New position
11/30/2023
0.00→52.09K
Common Stock
Direct
Shares
+47.91K
Price / share
$0.49
Trade value
$23.63K
% of position
92.0%
12/1/2023
52.09K→100K
Total
Net shares
+100K
Net value
$49.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/30/2023 | P · Purchase | +52.09K | $0.49 | $25.73K | New position | 0.00 | 52.09K |
| Common Stock Direct | 12/1/2023 | P · Purchase | +47.91K | $0.49 | $23.63K | 92.0% | 52.09K | 100K |
| Total | +100K | $49.36K | ||||||
Derivative Transactions0
No derivative transactions reported